AUTOLOMATE
LIVE

Serial Number

79301893

Owner

Autolomous Ltd

Attorney

Michelle Alvey

Filing Date

Oct 28, 2020

Add to watchlist:

No watchlists yet
View on USPTO

AUTOLOMATE Trademark

Serial Number: 79301893 • Registration: 6641505

AUTOLOMATE is a trademark filed by Autolomous Ltd on October 28, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Autolomous Ltd

17 Hanover Square,

Entity Type: 99

Trademark Details

Filing Date

October 28, 2020

Registration Date

February 15, 2022

Published for Opposition

November 30, 2021

Goods & Services

Downloadable computer software for digitizing records, scheduling of all critical manufacturing criteria, including inbound starting material, availability and assignment of manufacturing operatives, availability and assignment of manufacturing equipment, and availability and assignment of GMP cleanroom, and quality approval of the manufacturing processes and specification of the drug product in the field of cell and gene therapy; recorded and downloadable computer software platforms for autologous medicines for digitizing records, scheduling of all critical manufacturing criteria, including inbound starting material, availability and assignment of manufacturing operatives, availability and assignment of manufacturing equipment, and availability and assignment of GMP cleanroom and quality approval of the manufacturing processes and specification of the drug product; downloadable computer software that enables users to digitise, upload and automate information relating to cell and gene therapy

Data management services in relation to autologous medicines, namely, electronic data collection and data submission services for business purposes in the field of autologous medicines; compilation of information relating to gene and cell therapy into computer databases; data hub services, namely, data processing services and management and compilation of computerised databases; systemization of information relating to autologous medicines into computer databases

Platform as a service (PAAS) featuring computer software platforms for autologous medicines for digitizing records, scheduling of all critical manufacturing criteria, including inbound starting material, availability and assignment of manufacturing operatives, availability and assignment of manufacturing equipment, and availability and assignment of GMP cleanroom and quality approval of the manufacturing processes and specification of the drug product in the field of cell and gene therapy; software as a service (SAAS) services featuring software for autologous medicines for digitizing and downloading records, scheduling of all critical manufacturing criteria, including inbound starting material, availability and assignment of manufacturing operatives, availability and assignment of manufacturing equipment, and availability and assignment of GMP cleanroom, and quality approval of the manufacturing processes and specification of the drug product in the field of cell and gene therapy; providing software as a service (SAAS) services featuring software that enables users to digitise, upload, download, and automate information relating to gene and cell therapy

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 16, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 21, 2022 FICS
FINAL DISPOSITION PROCESSED
Jul 21, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 15, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 15, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Dec 6, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 30, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 30, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 17, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 17, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 10, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 25, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 25, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 25, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 25, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 25, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 5, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 5, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 5, 2021 TROA
REFUSAL PROCESSED BY IB
Apr 25, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 6, 2021 RFCS
REFUSAL PROCESSED BY MPU
Apr 6, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 31, 2021 RFCR
NON-FINAL ACTION WRITTEN
Mar 30, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 30, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 12, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 7, 2021 REPR